![]() | ![]() | ![]() |
---|
Research Areas of Focus
The ASRC Sensor CAT advances the field of sensor technology through scientific research projects which investigate:
-
Novel molecular sensing modalities and materials
-
Cutting-edge development of sensor devices
-
Nanoscale sensor technology and ultrasensitive sensors
-
Interfaces between sensors and their (biological) environments
We welcome projects with a wide-range of applications to improve and understand human and environmental health through sensor technology.
On-Going Research Application Areas
Detection of SARS-CoV-2 virus (coronavirus that causes COVID-19)
-
Optical diagnostic device, Vyir, Inc.
-
Viral glycan sensing receptors, Dultech
High-throughput device for 3D cell cultures, Vivo Z
Our Projects

ASTRABEAM
New York, New York
Advanced Science Research Center
A Semiconductor Company Innovates Wireless Sensing Solutions for Safety, Security and Healthcare.

INSURGENT
New York, New York
Advanced Science Research Center
Insurgent Tech disrupts the healthcare industrial complex by creating products and services that: allow people to take more control of their health, allow practitioners to provide better diagnosis and personalized care, expand availability and efficiency of health services, reduce health costs.

SEEQC
New York, New York
Advanced Science Research Center
SEEQC is built upon the fundamental premise that to deliver a commercially scalable and cost-effective quantum computing solution, classical readout, control, error correction, and data processing functions must be integrated with a quantum processor.

VADER NANOTECH
New York, New York
Advanced Science Research Center
Our patented approach uses image analysis to select for organisms with the ability to grow on plastic, PFAS, and other difficult to break down chemicals as a sole carbon source. Using directed evolution techniques we optimize these organisms and improve their performance.

FREZENT BIOLOGICAL SOLUTIONS
New York, New York
Advanced Science Research Center
Frezent is pioneering senotherapeutics for the treatment of patients with solid tumors. The company is developing biological inhibitors of cancer-specific lipid metabolism. These inhibitors can be effectively applied to target dormant (senescent) cancer cells that escaped chemotherapy and prevent their reactivation.

GREEN MATERIALS SCIENCES
New York, New York
City College of New York
Developing an environmental detection platform focused on PFAS (aka forever chemicals).

UTR THERAPEUTICS
New York, New York
Hunter College
UTR Therapeutics Inc. is a Pre-Clinical Stage biotech company with a first-in-class technology that can overwrite any target of interest. We’ve proven this robustly in difficult to treat cancers and are ready to scale into Neurodegenerative and Rare Diseases.